
Clearside Biomedical
- Home
- Companies
- Clearside Biomedical
- Products
- Clearside XIPERE - Triamcinolone ...

Clearside XIPERE - Triamcinolone Acetonide Injectable Suspension
FIRST commercial product developed by Clearside; FIRST approved therapeutic delivered into the suprachoroidal space; FIRST therapy for macular edema associated with uveitis; FIRST uveitis trial using visual acuity change as a primary endpoint (Phase 3 PEACHTREE).
Most popular related searches
XIPERE is a proprietary suspension of the corticosteroid triamcinolone acetonide for use with the SCS Microinjector® and indicated for the treatment of macular edema associated with uveitis.
XIPERE has received U.S. FDA approval. Please see Important Safety Information for XIPERE in the Accompanying Full Prescribing Information here.